Journal of Nihon University Medical Association
Online ISSN : 1884-0779
Print ISSN : 0029-0424
ISSN-L : 0029-0424
Volume 73, Issue 6
Journal of Nihon University Medical Association
Displaying 1-7 of 7 articles from this issue
Review:
  • Ryouichi Tomita, Kiminobu Sugito, Taro Ikeda, Seigo Igarashi, Mikiya I ...
    2014 Volume 73 Issue 6 Pages 243-247
    Published: December 01, 2014
    Released on J-STAGE: May 22, 2015
    JOURNAL FREE ACCESS
    We describe the physiological examination of anorectal function in children with chronic constipation (CC), including Hirschsprung's (H) disease (aganglionosis) and its allied disorders [hypoganglionosis (Hypo) and intestinal neuronal dysplasia (IND)]. The assessments are summarized as follows: 1) Anorectal manometry: Enteric nervous system, especially non-adrenergic non-cholinergic excitatory and inhibitory nerves, controls the ano-rectal sphincter reflex. Therefore, patients with aganglionosis lack ano-rectal sphincter reflexes. Abnormalities of the enteric nervous system in Hypo and IND show atypical sphincter reflexes. In contrast, CC patients exhibit normal sphincter reflexes. 2) Terminal motor latency in the pudendal and sacral nerves: Patients with aganglionosis, Hypo, IND and CC exhibit conduction delay of these nerves. These findings may suggest damage to the pudendal and sacral motor nerves due to straining during defecation. 3) Anal canal sensation test (anal canal mucosal electrosensitivity and somatosensory evoked potential tests): Anal sensation is decreased in patients with H disease, Hypo, IND and CC. These findings may suggest damage to the pudendal sensory nerves due to straining during defecation. 4) Defecography: This examination easily detects an obstructive type in school-age patients with CC. 5) Gastrointestinal transit time: This examination easily detects the slow transit type in school-age patients with CC. Conclusions: It is easy for pediatric surgeons to evaluate physiological function in patients with CC, H disease and its allied diseases using physiological examinations.
    Download PDF (878K)
Original Article:
  • Motohiko Furuichi, Kiminobu Sugito, Mie Shimamura, Tatsuhiko Nishii, S ...
    2014 Volume 73 Issue 6 Pages 248-253
    Published: December 01, 2014
    Released on J-STAGE: May 22, 2015
    JOURNAL FREE ACCESS
    During the course of 4 years and 8 months, from January 2009 to August 2013, 737 patients underwent surgery with general anesthesia at our department. Perioperative heparinization was required in 28 of these patients (3.8%) because they had been treated with antithrombotic therapy prior to the operation. Oral antithrombotic agents were discontinued as part of the perioperative management after the patients had been hospitalized for one week prior to surgery, and the activated partial thromboplastin time was controlled at around 55-70 seconds with continuous intravenous administration of unfractionated heparin. The intravenous heparin administration was discontinued 6 hours before surgery. In all patients, surgery was performed safely, and oral medications were resumed on postoperative day 1. There were no significant differences in the operative time or blood loss between the heparinization and control groups. Among 316 patients with resectable malignant tumors of the lung, 20 (6.3%) received antithrombotic therapy before surgery. In the heparinization group, a significantly prolonged operative time was observed, but there was no significant increase in blood loss or the postoperative hospitalization period. These observations suggest that surgery with perioperative heparinization in patients receiving antithrombotic therapy can be performed safely similar to routine surgery.
    Download PDF (1148K)
Casel Reports:
topics
feedback
Top